Allegations of Waste, Fraud, and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs and the Federal Taxpayer : Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, First Session, February 9, 2007, Volume 4
United States. Congress. House. Committee on Oversight and Government Reform
€0